Login
$VIVS
$0.13 +$0.00 (1.86%) After hours

$VIVS SEC Filings

Filed On Filing
12 Nov 2026 10-Q
16 Oct 2026 8-K: Entry into a Material Definitive Agreement

THIS SECOND AMENDMENT TO AMENDED AND RESTATED LEASE (this "Second Amendment"), by and between SAN DIEGO INSPIRE 2, LLC, a Delaware limited liability company ("Landlord"), and ORGANOVO, INC., a Delaware corporation ("Tenant"), is made eff...

06 Oct 2026 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders

to attract and retain the best available personnel for positions of substantial responsibility,

01 Sep 2026 Form 4: Lialin Tony Serge, Chief Commercial Officer

Bought 10,000 shares ($2.8K)

21 Aug 2026 ARS
21 Aug 2026 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule

On August 17, 2026, VivoSim Labs, Inc., a Delaware corporation (the “Company”), received a written notice (the “Notice”) from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based...

21 Aug 2026 Proxy statement: annual meeting on September 30, 2026

CEO pay $866K, down 26% · say-on-pay vote

17 Aug 2026 SCHEDULE 13G/A
13 Aug 2026 PRER14A
12 Aug 2026 10-Q
10 Aug 2026 EFFECT
10 Aug 2026 PRE 14A
06 Aug 2026 8-K: Results of Operations and Financial Condition

San Diego, CA — August 6, 2026 — VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAM) 3d human cellular models for preclinical safety, today announced that on Augu...

31 Jul 2026 S-1
30 Jul 2026 8-K: Shareholder Director Nominations; Other Events

On July 30, 2026, the Board of Directors of VivoSim Labs, Inc. (the “Company”) set September 30, 2026 (the “Meeting Date”) as the date of the Company’s 2026 Annual Meeting of Stockholders (the “Annual Meeting”) and August 13, 2026 as the...

24 Jul 2026 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule; Other Events

On July 20, 2026, VivoSim Labs, Inc., a Delaware corporation (the “Company”), received a written notice (the “Notice”) from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, since t...

17 Jul 2026 8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more

This Securities Purchase Agreement (this “Agreement”) is dated as of July 16, 2026, between VivoSim Labs, Inc., a Delaware corporation (the “Company”), and each of the purchasers identified on the signature pages hereto (including its su...

14 Jul 2026 10-K
29 Jun 2026 NT 10-K
06 Apr 2026 SCHEDULE 13G

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support